tiprankstipranks
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
US Market
STRO
Sutro Biopharma
RESEARCH TOOLSreports

Sutro Biopharma (STRO) Financial Statements

718 Followers

Sutro Biopharma Financial Overview

Sutro Biopharma's market cap is currently $396.79M. The company's EPS TTM is $-5.29; its P/E ratio is -0.51; Sutro Biopharma is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is $-2.79. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 102.48M$ 62.04M$ 153.73M$ 67.77M$ 61.88M
Gross Profit$ 95.16M$ 54.83M$ 146.91M$ 59.48M$ 52.11M
Operating Income$ -104.95M$ -238.45M$ -89.28M$ -128.94M$ -98.52M
EBITDA$ -97.63M$ -180.45M$ -67.92M$ -105.07M$ -97.56M
Net Income$ -191.09M$ -227.46M$ -106.79M$ -119.20M$ -105.54M
Balance Sheet
Cash & Short-Term Investments$ 141.43M$ 316.89M$ 375.62M$ 334.36M$ 197.94M
Total Assets$ 173.83M$ 387.21M$ 470.74M$ 406.94M$ 341.41M
Total Debt$ 15.67M$ 23.15M$ 33.63M$ 55.02M$ 57.37M
Net Debt$ -42.46M$ -167.15M$ -35.63M$ 7.76M$ 26.96M
Total Liabilities$ 306.28M$ 342.61M$ 321.09M$ 189.90M$ 88.84M
Stockholders' Equity$ -132.45M$ 44.60M$ 149.65M$ 217.05M$ 252.56M
Cash Flow
Free Cash Flow$ -178.93M$ -194.64M$ -115.93M$ -4.31M$ -97.00M
Operating Cash Flow$ -177.23M$ -191.54M$ -111.62M$ 3.55M$ -81.68M
Investing Cash Flow$ 45.01M$ 218.51M$ -3.92M$ -35.02M$ -97.31M
Financing Cash Flow$ 44.00K$ 94.05M$ 137.55M$ 48.31M$ 3.26M
Currency in USD

Sutro Biopharma Earnings and Revenue History

Income Statement >

Sutro Biopharma Debt to Assets

Balance Sheet >

Sutro Biopharma Cash Flow

Cash Flow >

Sutro Biopharma Forecast EPS vs Actual EPS

Earnings >